Ra Capital Management, L.P. I Teos Therapeutics, Inc. Call Options Transaction History
Ra Capital Management, L.P.
- $6.17 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ITOS
# of Institutions
150Shares Held
33.4MCall Options Held
454KPut Options Held
2.45M-
Black Rock Inc. New York, NY3.73MShares$26 Million0.0% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$19.1 Million16.91% of portfolio
-
Bvf Inc San Francisco, CA2.33MShares$16.2 Million0.67% of portfolio
-
Jpmorgan Chase & CO New York, NY2.07MShares$14.4 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA1.75MShares$12.2 Million2.01% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $248M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...